(Press-News.org) New clinical research from UC San Francisco shows that 341 HIV-infected men who reported using stimulants such as methamphetamine or cocaine derived life-saving benefits from being on antiretroviral therapy that were comparable to those of HIV-infected men who do not use stimulants.
That said, those who reported using stimulants at more than half of at least two study visits did have modestly increased chances of progressing to AIDS or dying after starting antiretroviral therapy compared to non-users. The data was collected between 1996 and 2012.
"Patients with HIV who use stimulants and other substances often experience difficulties with accessing antiretroviral therapy, partially due to the concerns of healthcare providers that they will not be able take their medications as directed. Findings from this study demonstrate that many stimulant users take their antiretroviral therapy at levels sufficient to avoid negative clinical outcomes. When we look at overall mortality, antiretroviral therapy leads to similar clinical benefits for both stimulant users and non-users, notwithstanding stimulant use," said the study's primary investigator, Adam W. Carrico, PhD., UCSF assistant professor of nursing.
The research is available starting in October online ahead of print in the Journal of Acquired Immune Deficiency Syndromes. The study included 1,313 HIV-infected men who have sex with men within the Multicenter AIDS Cohort Study, an ongoing nationwide prospective study of HIV infection among men who have sex with men in the U.S.
"If we are to achieve the goals of the President's National HIV/AIDS Strategy and UNAIDS to end the HIV/AIDS epidemic, we will need to treat HIV-positive active substance users for their HIV while encouraging them to stop or reduce their substance use. Programs integrating substance abuse services with HIV clinical care may both improve health outcomes for patients and reduce new infections," said Carrico.
The UCSF Division of HIV/AIDS at San Francisco General Hospital has created an integrated care delivery system that could serve as a model for other clinics, added Carrico. The HIV primary care clinic utilizes a patient centered team care approach that includes substance abuse services for stimulant and opioid users, along with mental health services, all located onsite. STOP, the "stimulant treatment outpatient program," within the clinic provides outpatient substance abuse and mental health treatment integrated with patients' primary medical care.
"The pattern of use varies and the real issue is whether patients can take their antiretrovirals as prescribed. We find that some patients are able to start taking antiretrovirals very reliably before they are able to decrease or stop their stimulant use, which often requires more complex behavioral, emotional, interpersonal and environmental changes. Being in an HIV primary care setting allows us to engage stimulant users even if they are not ready to go to specialty substance abuse programs or support groups," said Valerie Gruber, PhD, STOP director and UCSF professor of psychiatry.
INFORMATION:
Study co-investigators include Stephen Shoptaw, PhD, from UCLA; Christopher Cox, PhD, and Xiuhong Li, MAS from Johns Hopkins University; Ronald Stall, PhD from the University of Pittsburgh; David G. Ostrow, MD, PhD, from the Chicago MACS and Ostrow & Associates, Chicago; Michael W. Plankey, PhD, from Georgetown University; and David Vlahow, RN, PhD, Dean of the UCSF School of Nursing.
The Multicenter AIDS Cohort Study (MACS) includes the following: Baltimore: The Johns Hopkins University Bloomberg School of Public Health: Joseph B. Margolick (Principal Investigator), Chicago: Howard Brown Health Center, Feinberg School of Medicine, Northwestern University, and Cook County Bureau of Health Services: John P. Phair (Principal Investigator), Joan S. Chmiel (Co-Principal Investigator), Los Angeles: University of California, UCLA Schools of Public Health and Medicine: Roger Detels (Principal Investigator), Barbara R. Visscher (Co-Principal Investigator), Pittsburgh: University of Pittsburgh, Graduate School of Public Health: Charles R. Rinaldo (Principal Investigator), Lawrence Kingsley (Co-Principal Investigator), The Johns Hopkins University Bloomberg School of Public Health: Lisa P. Jacobson (Principal Investigator), Alvaro Muñoz (Co-Principal Investigator), NIH: National Institute of Allergy and Infectious Diseases: Robin E. Huebner; National Cancer Institute: Geraldina Dominguez; National Heart, Lung and Blood Institute: Cheryl McDonald.
Funding for the research was provided by the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, the National Heart, Lung and Blood Institute, and the National Institute on Deafness and Communication Disorders.
The UCSF School of Nursing, affiliated with the AIDS Research Institute at UCSF, is one of the only programs to provide nurse practitioners with specialty training in HIV/AIDS, and in 2013 it ranked #1 in NIH funding nationwide. The AIDS Research Institute (ARI) at UCSF houses hundreds of scientists and dozens of programs throughout UCSF and affiliated labs and institutions, making ARI one of the largest AIDS research entities in the world. UCSF ranks #1 among medical schools in the U.S. for its AIDS programs according to US News & World Report, as it has every year since the category was created in 2001.
UCSF is the nation's leading university exclusively focused on health. Now celebrating the 150th anniversary of its founding as a medical college, UCSF is dedicated to transforming health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with world-renowned programs in the biological sciences, a preeminent biomedical research enterprise and two top-tier hospitals, UCSF Medical Center and UCSF Benioff Children's Hospital San Francisco.
Follow UCSF on Twitter @ucsf/@ucsfscience END
Antiretroviral therapy benefits HIV-infected stimulant users, UCSF study shows
2014-10-10
ELSE PRESS RELEASES FROM THIS DATE:
Pneumococcal vaccine reduces antibiotic-resistant infections in children by 62 percent
2014-10-10
PHILADELPHIA –The pneumococcal vaccine recommended for young children not only prevents illness and death, but also has dramatically reduced severe antibiotic-resistant infections, suggests nationwide research being presented at IDWeek 2014™. Pneumococcal infection – which can cause everything from ear infections to pneumonia and meningitis – is the most common vaccine-preventable bacterial cause of death.
The 13-valent pneumococcal conjugate vaccine (PCV13), first available in 2010 (replacing 7-valent pneumococcal conjugate vaccine, PCV7), reduced the ...
Real-life social networking prompts people to get tested for HIV
2014-10-10
PHILADELPHIA – Old-school face-to-face social networking is a more effective way to identify people with HIV than the traditional referral method, suggests research being presented at IDWeek 2014™. The study shows that social networking strategies (SNS) – enlisting people in high-risk groups to recruit their peers to get tested – is more efficient and targeted than traditional testing and referral programs, resulting in 2-1/2 times more positive test results.
As many as 20 percent of HIV-positive people are unaware of being infected with the virus, ...
Rare 'baby rattle' molecules reveal new quantum properties of H2O and H2
2014-10-10
The experiments were carried out on endofullerenes, molecules of C60 into which smaller molecules of Hydrogen (H2) had been inserted. The results, published in Physical Review Letters, represent the first known example of a quantum selection rule found in a molecule.
Similar techniques were also used by the same team to uncover an exciting new symmetry-breaking interaction of water molecules with C60 cages, published last month in Physical Chemistry Chemical Physics.
The use of fullerenes such as C60 to trap smaller molecules, using cutting-edge molecular surgery techniques, ...
Old textbook knowledge reconfirmed: Decay rates of radioactive substances are constant
2014-10-10
This news release is available in German.
The distance between the Earth and the Sun has no influence on the decay rate of radioactive chlorine. You could ask: "And why should it anyway?", because it is well known that the decay of radionuclides is as reliable as a Swiss clock. Recently, US-American scientists, however, attracted attention when they postulated that the decay rate depends on the flow of solar neutrinos and, thus, also on the distance from the Earth to the Sun. Their assumption was based, among other things, on older measurement data of the Physikalisch-Technische ...
Mineralization of sand particles boosts microbial water filtration
2014-10-10
WASHINGTON, DC – OCTOBER 10, 2014 - Mineral coatings on sand particles actually encourage microbial activity in the rapid sand filters that are used to treat groundwater for drinking, according to a paper published ahead of print in Applied and Environmental Microbiology. These findings resoundingly refute, for the first time, the conventional wisdom that the mineral deposits interfere with microbial colonization of the sand particles.
"We find an overwhelmingly positive effect of mineral deposits on microbial activity and density," says corresponding author Barth ...
Dangerous blood clots: A serious global problem
2014-10-10
A study on the global burden of venous thromboembolism—when a dangerous clot forms in a blood vessel—found that annual incidences range from 0.75 to 2.69 per 1,000 individuals in the population. The incidence increased to between 2 and 7 per 1,000 among those 70 years of age or more.
"Venous thromboembolism in hospitalized patients was responsible for more years lost due to ill-health than hospital-acquired pneumonia, catheter-related blood stream infections, and side effects from drugs," said Dr. Gary Raskob, co-author of the Journal of Thrombosis & Haemostasis ...
Researchers find RNA molecules in urine and tissue that detect prostate cancer
2014-10-10
Philadelphia, PA, October 9, 2014 – Researchers at Sanford-Burnham Medical Research Institute have identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients but not in normal healthy individuals. The study sets the stage for the development of more sensitive and specific noninvasive tests for prostate cancer than those currently available, which could result in fewer unnecessary prostate biopsies with less treatment-related morbidity, according to a new study in The Journal of Molecular Diagnostics.
According to ...
Stanford team invents sensor that uses radio waves to detect subtle changes in pressure
2014-10-10
Stanford engineers have invented a wireless pressure sensor that has already been used to measure brain pressure in lab mice with brain injuries.
The underlying technology has such broad potential that it could one day be used to create skin-like materials that can sense pressure, leading to prosthetic devices with the electronic equivalent of a sense of touch.
A nine-member research team led by Chemical Engineering Professor Zhenan Bao detailed two medical applications of this technology in Nature Communications.
In one simple demonstration they used this wireless ...
Similar but different: New discovery for degenerative disease
2014-10-10
Researchers from the University of Melbourne have established how two diseases that present in similar ways are in fact quite different.
Progressive Supranuclear palsy and Parkinson's Disease have overlapping symptoms but remain difficult to distinguish.
However, a first ever paper on the topic published in the Journal of Neuropsychology (British Psychological Society publication) now suggests that people with PSP experience more severe and extensive cognitive impairments than those with PD early on.
The study indicates that patients with PSP experience more severe ...
Longer-term outcomes of program to reduce unnecessary antibiotic prescriptions
2014-10-10
The initial benefits of an outpatient antimicrobial stewardship intervention designed to reduce the rate of inappropriate antibiotic prescriptions were lost after discontinuation of audit and feedback to clinicians, according to a study published in JAMA. The study is being released early online to coincide with the IDWeek 2014 meeting.
Antibiotics are the most frequently prescribed medications for children; most are prescribed for outpatient acute respiratory tract infections. Because antibiotic prescribing is often inappropriate, Jeffrey S. Gerber, M.D., Ph.D., of ...